Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

To Close Equity Gaps With New PCI-Capable Hospitals, Location Matters

Michael O'Riordan

December 18, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Caitlin E. Cox

October 27, 2023

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

News Daily News

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

L.A. McKeown

September 14, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Conference News ESC 2023

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Michael O'Riordan

August 26, 2023

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Michael O'Riordan

July 18, 2023

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

News Conference News SCAI 2023

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

L.A. McKeown

May 31, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

News Conference News EuroPCR 2023

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Michael O'Riordan

May 19, 2023

Presentation EuroPCR 2023

BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent

Presenter: Shigeru Saito

May 18, 2023

News Conference News EuroPCR 2023

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Michael O'Riordan

May 18, 2023

News Daily News

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Michael O'Riordan

May 09, 2023

Advertisement

Top Coronary Artery Disease News of 2023

To Close Equity Gaps With New PCI-Capable Hospitals, Location Matters

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

CABG and PCI Comparable in ACS Patients With Left Main CAD

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content